GetTopicDetailResponse(id=72c111355422, topicName=貝格列凈, introduction=貝格列凈, content=2型糖尿病 達(dá)格列凈 貝格列凈, image=null, comments=0, allHits=963, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Apr 20 15:25:48 CST 2024, time=2024-04-20, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=489651, tagList=[TagDto(tagId=489651, tagName=貝格列凈)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2199445, encodeId=ddb72199445af, content=<a href='/topic/show?id=d20f1090c2' target=_blank style='color:#2F92EE;'>#2型糖尿病#</a> <a href='/topic/show?id=d90393941be' target=_blank style='color:#2F92EE;'>#達(dá)格列凈#</a> <a href='/topic/show?id=72c111355422' target=_blank style='color:#2F92EE;'>#貝格列凈#</a>, objectTitle=J Diabetes：貝格列凈與達(dá)格列凈聯(lián)合二甲雙胍治療中國2型糖尿病患者的療效和安全性比較, objectType=article, longId=822375, objectId=84f68223e5be, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668024406447_4754896.jpeg, objectUrl=/article/show_article.do?id=84f68223e5be, replyNumber=0, likeNumber=161, createdTime=2024-04-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=84f68223e5be, moduleTitle=J Diabetes：貝格列凈與達(dá)格列凈聯(lián)合二甲雙胍治療中國2型糖尿病患者的療效和安全性比較, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=84f68223e5be)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-04-20發(fā)表于上海
